NCT04594954 - Fecal Microbiota Transplantation (FMT) & Non-Alcoholic Fatty Liver Disease (NAFLD) / Metabolic dysfunction-associated fatty liver disease (MAFLD)

Study overview

This is a randomized clinical treatment trial studying Fecal Microbiota Transplantation (FMT) + Diet + Exercise or Diet + Exercise in patients with Non-Alcoholic Fatty Liver Disease (NAFLD) / Metabolic dysfunction-associated fatty liver disease (MAFLD)

Primary outcome measures

Proportion of patients achieving ≤ 5%of the weight loss in kg from baseline

Results

No published results were found as of March 2016

…